Abstract
The CheckMAP tool provides a list of signalling questions to consider when checking and appraising an individual participant data (IPD) meta-analysis project, and answers of ‘yes’ to questions are indicative of higher quality. A summary of the CheckMAP assessment provides a useful overview of the quality of a particular IPD meta-analysis project. A key component of appraising an IPD meta-analysis project evaluating the treatment effects is determining whether it has been done as part of a systematic review. As for conventional systematic reviews, IPD meta-analysis projects require that explicit objectives and eligibility criteria are pre-specified to minimise bias in the selection of trials, participants and outcomes for inclusion. Clear objectives and eligibility criteria should have been backed up by a systematic and comprehensive search that seeks to identify all relevant trials. CheckMAP checklist and guidance on critical appraisal has focused on IPD meta-analyses that examine the efficacy of one particular treatment compared to a control.
Original language | English |
---|---|
Title of host publication | Individual Participant Data Meta-Analysis |
Subtitle of host publication | a Handbook for Healthcare Research |
Publisher | Wiley-Blackwell Publishing Ltd |
Chapter | 11 |
Pages | 271-283 |
Number of pages | 13 |
ISBN (Electronic) | 9781119333784 |
ISBN (Print) | 9781119333722 |
DOIs | |
Publication status | Published - 22 Apr 2021 |
Bibliographical note
Publisher Copyright:© 2021 John Wiley & Sons Ltd. All rights reserved.